Arcutis Biotherapeutics, Inc.'s revenue has grown 241% a year over three years. Revenue growth, 3-year annual rate: +241% (Biotechnology median +21%). Years of annual history on file: 8, FY2018 to FY2025, as filed.

ARQTArcutis Biotherapeutics, Inc.

Healthcare

$31.21+49% 1Y

$31.21

$19.5052 weeks$32.80

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +76% year on year and operating margin widening (+45.0 points), but earnings down −128% year on year.

2 good, 1 to watch

Revenue trend+76% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend−128% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+45.0 points operating

Trailing-twelve-month operating margin, 6.7% now against -38.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearstop 1% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.